B. F. El-Rayes

1.5k total citations
38 papers, 1.2k citations indexed

About

B. F. El-Rayes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, B. F. El-Rayes has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in B. F. El-Rayes's work include Colorectal Cancer Treatments and Studies (14 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cancer Treatment and Pharmacology (7 papers). B. F. El-Rayes is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cancer Treatment and Pharmacology (7 papers). B. F. El-Rayes collaborates with scholars based in United States and France. B. F. El-Rayes's co-authors include Philip A. Philip, Patricia LoRusso, Fazlul H. Sarkar, Shadan Ali, Anthony F. Shields, Ulka N. Vaishampayan, Lance K. Heilbrun, Mark M. Zalupski, Maha Hussain and Edgar Ben‐Josef and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

B. F. El-Rayes

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. F. El-Rayes United States 19 615 385 348 220 166 38 1.2k
Eijiro Nakamura Japan 19 574 0.9× 472 1.2× 512 1.5× 241 1.1× 233 1.4× 59 1.4k
Chung-Tsen Hsueh United States 19 556 0.9× 305 0.8× 416 1.2× 200 0.9× 112 0.7× 55 1.2k
Masanori Tsujie Japan 19 737 1.2× 381 1.0× 443 1.3× 274 1.2× 442 2.7× 99 1.4k
Lucas Wong United States 16 685 1.1× 247 0.6× 429 1.2× 124 0.6× 158 1.0× 50 1.3k
Fumio Nakagawa Japan 20 682 1.1× 299 0.8× 381 1.1× 118 0.5× 150 0.9× 61 1.2k
Hao‐Wei Teng Taiwan 21 788 1.3× 254 0.7× 576 1.7× 270 1.2× 189 1.1× 73 1.4k
Gregory H. Ripple United States 14 520 0.8× 333 0.9× 272 0.8× 152 0.7× 291 1.8× 22 978
Dale R. Shepard United States 17 478 0.8× 470 1.2× 419 1.2× 258 1.2× 115 0.7× 75 1.2k
Luka Milas United States 19 643 1.0× 376 1.0× 489 1.4× 257 1.2× 90 0.5× 41 1.4k
Tao Sun China 19 672 1.1× 451 1.2× 379 1.1× 185 0.8× 187 1.1× 92 1.4k

Countries citing papers authored by B. F. El-Rayes

Since Specialization
Citations

This map shows the geographic impact of B. F. El-Rayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. F. El-Rayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. F. El-Rayes more than expected).

Fields of papers citing papers by B. F. El-Rayes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. F. El-Rayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. F. El-Rayes. The network helps show where B. F. El-Rayes may publish in the future.

Co-authorship network of co-authors of B. F. El-Rayes

This figure shows the co-authorship network connecting the top 25 collaborators of B. F. El-Rayes. A scholar is included among the top collaborators of B. F. El-Rayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. F. El-Rayes. B. F. El-Rayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smyth, Elizabeth, Peter C. Enzinger, Michele Vincitore, et al.. (2011). Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U.S. experience.. Journal of Clinical Oncology. 29(15_suppl). 4056–4056. 3 indexed citations
2.
El-Rayes, B. F., Nazik Hammad, P. A. Philip, A. F. Shields, & L. K. Heilbrun. (2008). A phase II study of bevacizumab, docetaxel and oxaliplatin in gastric and gastroesophageal junction (GEJ) cancer. Journal of Clinical Oncology. 26(15_suppl). 15608–15608. 10 indexed citations
3.
El-Rayes, B. F., Mark M. Zalupski, Anthony F. Shields, et al.. (2005). A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer. Investigational New Drugs. 23(6). 583–590. 75 indexed citations
4.
Ali, Shadan, B. F. El-Rayes, Olivia Aranha, Fazlul H. Sarkar, & Philip A. Philip. (2005). Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells. Breast Cancer Research and Treatment. 90(1). 25–31. 17 indexed citations
5.
El-Rayes, B. F., Camille S. Norton, Wael Sakr, et al.. (2005). Cellular DNA content parameters as prognostic indicators in human astrocytomas. Journal of Neuro-Oncology. 71(2). 85–89. 4 indexed citations
6.
El-Rayes, B. F., Anthony F. Shields, Mark M. Zalupski, et al.. (2005). A Phase II Study of Carboplatin and Paclitaxel in Adenocarcinoma of Unknown Primary. American Journal of Clinical Oncology. 28(2). 152–156. 24 indexed citations
7.
El-Rayes, B. F., Shadan Ali, Fazlul H. Sarkar, & Philip A. Philip. (2004). Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines. Molecular Cancer Therapeutics. 3(11). 1421–1426. 67 indexed citations
8.
El-Rayes, B. F., Anthony F. Shields, Ulka N. Vaishampayan, et al.. (2004). Phase II study of capecitabine, irinotecan, and celecoxib in advanced colorectal cancer. Journal of Clinical Oncology. 22(14_suppl). 3766–3766. 18 indexed citations
9.
El-Rayes, B. F., Anthony F. Shields, Mark M. Zalupski, et al.. (2004). A phase II study of carboplatin and paclitaxel in esophageal cancer. Annals of Oncology. 15(6). 960–965. 41 indexed citations
10.
El-Rayes, B. F. & Patricia LoRusso. (2004). Targeting the epidermal growth factor receptor. British Journal of Cancer. 91(3). 418–424. 144 indexed citations
11.
Ben‐Josef, Edgar, Anthony F. Shields, Ulka N. Vaishampayan, et al.. (2004). Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 59(2). 454–459. 149 indexed citations
12.
El-Rayes, B. F., Shadan Ali, Lance K. Heilbrun, et al.. (2003). Cytochrome p450 and glutathione transferase expression in human breast cancer.. PubMed. 9(5). 1705–9. 62 indexed citations
13.
El-Rayes, B. F., et al.. (2003). Hormone-refractory prostate cancer responding to capecitabine. Urology. 61(2). 462–462. 7 indexed citations
14.
El-Rayes, B. F., et al.. (2003). Developments in the Systemic Therapy of Pancreatic Cancer. Cancer Investigation. 21(1). 73–86. 28 indexed citations
15.
Hussain, Maha, David C. Smith, B. F. El-Rayes, et al.. (2003). Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locallyadvanced prostate cancer. Urology. 61(4). 774–780. 93 indexed citations
16.
El-Rayes, B. F., Kambeez Berenji, Paula Schuman, & Philip A. Philip. (2002). Breast Cancer in Women with Human Immunodeficiency Virus Infection: Implications for Diagnosis and Therapy. Breast Cancer Research and Treatment. 76(2). 111–116. 23 indexed citations
17.
El-Rayes, B. F. & Maha Hussain. (2002). Hormonal therapy for prostate cancer: past, present and future. Expert Review of Anticancer Therapy. 2(1). 37–47. 18 indexed citations
18.
El-Rayes, B. F., et al.. (2002). Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells. International Journal of Oncology. 21(1). 207–11. 52 indexed citations
19.
El-Rayes, B. F. & Philip A. Philip. (2002). Systemic therapy for advanced pancreatic cancer. Expert Review of Anticancer Therapy. 2(4). 426–436. 7 indexed citations
20.
El-Rayes, B. F., Volkan Adsay, & Philip A. Philip. (2001). Pancreatic cancer: the evolving role of systemic therapy. Expert Opinion on Pharmacotherapy. 2(12). 1939–1947. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eijiro Nakamura Breakdown of academic impact, for papers by Chung-Tsen Hsueh Breakdown of academic impact, for papers by Masanori Tsujie Breakdown of academic impact, for papers by Lucas Wong Breakdown of academic impact, for papers by Fumio Nakagawa Breakdown of academic impact, for papers by Hao‐Wei Teng Breakdown of academic impact, for papers by Gregory H. Ripple Breakdown of academic impact, for papers by Dale R. Shepard Breakdown of academic impact, for papers by Luka Milas Breakdown of academic impact, for papers by Tao Sun
Rankless by CCL
2026